Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

Cited by (1,001)

Items 901–1,000 of 1,001

1. Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO): protocol for a prospective observational study
   Ifigenia Vasiliadou, Christiana Cattaneo, Phoebe Yuen Ka Chan, Rhonda Henley‐Smith, Harry Gregson-Williams, Lisette Collins, Gabriella Wojewodka, Teresa Guerrero Urbano, Jean‐Pierre Jeannon, Steve E. J. Connor et al. · 2024 · BMJ Open
2. Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report
   Yonggang He, Zheng Wang, Jing Li, Xi Wang, Chong-Yu Zhao, Xiaobing Huang, Lu Zheng · 2024 · World Journal of Gastrointestinal Oncology
3. Establishment of two novel organoid lines from patients with combined hepatocellular cholangiocarcinoma
   Yun Gao, Xiaoyun Chen, Yuerong Zhu, Suiqing Zhou, Long Zhang, Qiuyue Wu, Hui Zhang, Ziyi Wang, Xuejiao Chen, Xinyi Xia et al. · 2024 · Human Cell
4. A three-dimensional mouse liver organoid platform for assessing EDCs metabolites simulating liver metabolism
   Ji Hyun Moon, Hyun-Soo Roh, Young-Jae Park, Hyun Ho Song, Jieun Choi, Da Woon Jung, Soo Jin Park, Ho Jin Park, So-Hyeon Park, Daeun Kim et al. · 2025 · Environment International
5. The latest progress of personalized drug screening and therapy research for common clinical tumors through the PDX model platform
   Yuliang Yuan, Hongling Gao, Yanhong Li, Xiangying Jiao · 2025 · Journal of Pharmaceutical Analysis
6. High-dimensional signalling analysis of organoids
   Aurélie Dobric, Christopher J. Tape · 2025 · Current Opinion in Cell Biology
7. Establishment and molecular characterisation of patient-derived organoids for primary central nervous system lymphoma
   Shengjie Li, Jun Ren, Jianing Wu, Zuguang Xia, Yingzhu Li, Chengxun Li, Wenjun Cao · 2025 · Leukemia
8. HIF‐1α‐induced long noncoding RNA LINC02776 promotes drug resistance of ovarian cancer by increasing polyADP‐ribosylation
   Yangjun Wu, Yu Zeng, Yong Wu, Xinyu Ha, Zheng Feng, Chaohua Liu, Ziqi Liu, Jiajia Wang, Xingzhu Ju, Shenglin Huang et al. · 2025 · Clinical and Translational Medicine
9. The Antibody–Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma
   Racha Hosni, Niklas Klümper, Christine Sanders, Sana Hosni, Vittorio Branchi, Alexander Semaan, Abdullah Alajati, Natalie Pelusi, Susanna S. Ng, Damian Johannes Ralser et al. · 2025 · Molecular Cancer Therapeutics
10. Tumor organoids: A review of culture methods, applications in cancer research, precision medicine, and drug development
    Chuan‐Hsin Chang, Chung-Che Tsai, Ching‐Feng Cheng, Tin-Yi Chu, Chun‐Pin Chiang, Yi‐Pang Lee, Chao‐Chuan Wu, Jiann‐Hwa Chen, Chan‐Yen Kuo, Po-Chih Hsu · 2025 · Tzu Chi Medical Journal
11. Applications of 3D models in cholangiocarcinoma
    Agata Montagner, Laura Lemberger-Viehmann, Nadine Reitberger, Milena Schmidt, Julia Scheruebl, Eric Pion, Benedikt J. Wagner, Christian P. Pilarsky, Robert Grützmann, Thiha Aung et al. · 2025 · Frontiers in Oncology
12. Organoid for Air Pollution Toxicity Assessment: Advances and Environmental Applicability
    Yin Jia, Di Wu, Chen Xiu, Zeming Ye, Qing X. Li · 2025 · Environment & Health
13. Engineering Complexity: Advances in 3D Breast Cancer Models for Precision Oncology
    Wonwoo Jeong, Sang Jin Lee · 2025 · Advanced Healthcare Materials
14. Advancements and challenges in culturing patient-derived cancer cells for personalized therapeutics
    Yatian Fu, Bee Luan Khoo, Chwee Teck Lim · 2025 · Frontiers in Lab on a Chip Technologies
15. Mastering Organoid Growth: A Complete Guide to Overcoming Methodological Challenges
    Chunbao Jiao, Omer Faruk Karakaya, Neda Dadgar, Chase J. Wehrle, Zahra Massoud, Hanna Hong, Robert L. Fairchild, Nic D. Leipzig, Federico Aucejo, Wen Wee Ma et al. · 2026 · MedComm
16. Tumor organoids on-a-chip and the role of AI in predictive oncology and personalized cancer medicine
    Maryam Sadat Mirlohi, Erfan Hamdi, Mohammad Hossein Karimi, Siamak Salami, Amir Reza Aref, Hamed Gilzad Kohan, Ali Ghayoor, Amir Seyfoori, Mohsen Akbari · 2026 · Biofabrication
17. The promise and potential of liver organoids: Development, classification and application
    Yuheng Wang, Zhichao Ye, Yiheng Lin, Yujie Zhao, Danyang Zhong, Jiang Chen, Jun Yin, Jianing Yan, Yifan Wang · 2026 · TransMed
18. Organoids in cancer therapy: translational applications and clinical promise
    Mingzhen Bai, Maoyun Liu, Sheng Wang, Ming Ran, Jingyuan Ye, 薛玉芹, Cheng Zhang, Yi Wang, Jiale Lu, Fengsheng Dai et al. · 2026 · Molecular Cancer
19. Thinking in 3 dimensions: philosophies of the microenvironment in organoids and organs-on-chip
    Silvia Caianiello, Marta Bertolaso, Guglielmo Militello · 2023 · History & Philosophy of the Life Sciences
20. Liver organoids as a primary human model to study HBV-mediated Hepatocellular carcinoma. A review
    Simran Sharma, Preety Rawal, Savneet Kaur, Rekha Puria · 2023 · Experimental Cell Research
21. Organoids for Cancer Research: Advances and Challenges
    Miaomaio Xin, Qian Li, Dongyang Wang, Zheng Wang · 2024 · Advanced Biology
22. Organoid as a promising tool for primary liver cancer research: a comprehensive review
    Xuekai Hu, Jiayun Wei, Pinyan Liu, Qiuxia Zheng, Yue Zhang, Qichen Zhang, Jia Yao, Jingman Ni · 2024 · Cell & Bioscience
23. Antitumor effects of inhibitors of ERK and Akt pathways in canine histiocytic sarcoma cell lines
    Hiroki Sakuma, Hirotaka Tomiyasu, Akiyoshi TANI, Yuko Goto‐Koshino, Hiroyuki Tani, Koichi Ohno, Hajime Tsujimoto, Makoto Bonkobara, Masaru Okuda · 2024 · The Veterinary Journal
24. Establishing a cryopreserved biobank of living tumor tissues for drug sensitivity testing
    Ping Chen, Jingbo Zhou, Xiangpeng Chu, Yangyang Feng, Qibing Zeng, Josh-Haipeng Lei, Ka-Pou Wong, Tai-Ip Chan, Chon-Wa Lam, Wenli Zhu et al. · 2024 · Bioactive Materials
25. Cholangiocyte organoids for disease, cancer, and regenerative medicine
    Munemasa Nagao, Akihisa Fukuda, Hirotaka Kashima, Sho Matsuyama, Kei Iimori, Shinnosuke Nakayama, Kenta Mizukoshi, Munenori Kawai, Go Yamakawa, Mayuki Omatsu et al. · 2024 · European Journal of Cell Biology
26. Significance of mouse xenograft tumor model using patient-derived cancer organoids for clinical drug development
    Hisataka Ogawa, Keiichi Yoshida, Shinichiro Hasegawa, Hiroshi Wada, Masayoshi Yasui, Hideaki Tahara · 2025 · Frontiers in Oncology
27. High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
    Arisa Higa, Nobuhiko Takahashi, Gen Hiyama, Hirosumi Tamura, Hirotaka Hoshi, Kenju Shimomura, Shinya Watanabe, Motoki Takagi · 2021 · Journal of Visualized Experiments
28. Advanced Xenograft Model with Cotransplantation of Patient-Derived Organoids and Endothelial Colony-Forming Cells for Precision Medicine
    Junhye Kwon, Sungryong Oh, Misun Park, Joon Seog Kong, Sunyi Lee, Hyunsook Lee, Younjoo Kim, Kyu‐Tae Kang, Ui Sup Shin, Joohee Jung · 2021 · Journal of Oncology
29. HepG2-NIAS cells, a new subline of HepG2 cells that can enhance not only CYP3A4 activity but also expression of drug transporters and form bile canaliculus-like networks by the oxygenation culture via a collagen vitrigel membrane
    Toshiaki Takezawa, Miaki Uzu · 2022 · The Journal of Toxicological Sciences
30. Organoids and Commercialization
    Anubhab Mukherjee, Aprajita Sinha, Maheshree Maibam, Bharti Bisht, Manash Kumar Paul · 2022 · Biomedical engineering
31. Tumor-Specific CircRNA-Derived Antigen Peptide Identification for Hepatobiliary Tumors
    Wenwen Wang, Lili Ma, Xing Zheng, Tinggan Yuan, Jinxia Bao, Yanjing Zhu, Xiaofang Zhao, Yan Zhao, Yali Zong, Yani Zhang et al. · 2022 · Engineering
32. MiR-3960 inhibits bladder cancer progression via targeting of DEXI
    Wenqing Li, Zihao Wang, Ziming Jiang, Yan Yan, Yan Yan, Zhenzhen Pan, Lin Chen, Fei Wang, Ming Wang, Zhihai Qin · 2023 · Biochemical and Biophysical Research Communications
33. Modeling Liver Development and Disease in a Dish
    Waqas Iqbal, Yaru Wang, Pingnan Sun, Xiaoling Zhou · 2023 · International Journal of Molecular Sciences
34. Targeting Dysregulated Ion Channels in Liver Tumors with Venom Peptides
    Achimba, Favour, Faezov, Bulat, Cohen, Brandon, Dunbrack, Roland, Holford, Mandë · 2024 · Molecular Cancer Therapeutics
35. Free-floating patient-derived organotypic tumor spheroids (PDOTS) from non-small cell lung cancer (NSCLC) tumors: a versatile tool for personalized testing of chemotherapeutic drugs
    Lilian Ismail, Komal Zahid, Anna Polyanskaya, Aya Al Othman, Ningfei Shen, Xiaoli Qi, Rushan A. Sulimanov, Yuri Esakov, Vladimir A. Makarov, Gleb I. Filkov et al. · 2025 · Research in Pharmaceutical Sciences
36. Bile as a liquid biopsy matrix: potential applications and limitations
    María Arechederra, María Rullán, Daniel Oyón, Matias Antonio Avila, Jesús Urmán, Carmen Berasain · 2024 · Exploration of Digestive Diseases
37. Bibliometric analysis of global research on human organoids
    Huanyu Li, Daofeng Wang, Cheong Wong Ho, Dan Shan · 2024 · Heliyon
38. Drug development and clinical trial design in pancreatico-biliary malignancies
    Jennifer Harrington, Louise Carter, Bristi Basu, Natalie Cook · 2018 · Current Problems in Cancer
39. Liver Organoids Generated from Mice with Necrotizing Enterocolitis Have Reduced Regenerative Capacity
    Hiromu Miyake, Carol Lee, Shogo Seo, Bo Li, Agostino Pierro · 2019 · European Journal of Pediatric Surgery
40. Expansion of Rare Cancer Cells into Tumoroids for Therapeutic Regimen and Cancer Therapy
    Myagmartsend Enkhbat, Yung‐Chiang Liu, Jua Kim, Yanshan Xu, Yin Zongyi, Tzu‐Ming Liu, Chu‐Xia Deng, Chang Zou, Xi Xie, Xiaowu Li et al. · 2021 · Advanced Therapeutics
41. Studying the Role of Chromosomal Instability (CIN) in GI Cancers Using Patient-derived Organoids
    Shalaka Patil, Sanika Jahagirdar, Maithilee Khot, Kundan Sengupta · 2021 · Journal of Molecular Biology
42. Organoids as tools for fundamental discovery and translation—a Keystone Symposia report
    Jennifer Cable, Matthias P. Lütolf, Jianping Fu, Sunghee Estelle Park, Athanasia P. Apostolou, Shuibing Chen, Cheng Jack Song, Jason R. Spence, Prisca Liberali, Madeline A. Lancaster et al. · 2022 · Annals of the New York Academy of Sciences
43. Single-Cell Resolution Three-Dimensional Imaging of Intact Organoids
    Ravian L. van Ineveld, Hendrikus CR Ariese, Ellen J. Wehrens, Johanna F. Dekkers, Anne C. Rios · 2020 · Journal of Visualized Experiments
44. Loss of RNF43/ZNRF3 predisposes to Hepatocellular carcinoma by impairing liver regeneration and altering liver fat metabolism
    Gianmarco Mastrogiovanni, Clare Pacini, Sofia Kakava, Robert Arnes‐Benito, Charles Richard Bradshaw, Susan E. Davies, Kourosh Saeb‐Parsy, Bon‐Kyoung Koo, Meritxell Huch · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
45. Development of Liver Cancer Organoids: Reproducing Tumor Microenvironment and Advancing Research for Liver Cancer Treatment
    Kangkang Li, Kuiwu Ren, Sen Du, Xiang Gao, Jiangtao Yu · 2024 · Technology in Cancer Research & Treatment
46. Establishment of matched bladder cancer PDX and PDX-derived organoid model and evaluation of anti-tumor efficacy of abemaciclib
    Xiongbing Lu, Chao Hu, Lingxing Duan, Ke Chen, Hua Hao, Yuanqiao He · 2024 · Clinical & Translational Oncology
47. Dynamic culture system advances the applications of breast cancer organoids for precision medicine
    Jun Jie Yang, Junyuan Qu, Mei Zhang, Xiang Li, Qian Jiang, Jinxiu Kang, Pan Nie, Na Jing, Xianling Wang · 2025 · Scientific Reports
48. Combination of tumor organoids with advanced technologies: A powerful platform for tumor evolution and treatment response (Review)
    Ying Hua Wu, Fan Zhang, Furong Du, Juan Huang, Shuqing Wei · 2025 · Molecular Medicine Reports
49. Longitudinal, label-free, high-resolution imaging of glioblastoma spheroid response to therapy: a translational tool for preclinical evaluation of chemotherapy, radiation, and immunotherapy
    Caroline E. Serafini, Amin Davarzani, Dan Cappabianca, Zhenmin Li, Daniela Baez Collazos, Deniz Mamaghani, Leidong Mao, Krishanu Saha, Lohitash Karumbaiah, Francisco E. Robles · 2025 · Optica
50. Engineering liver organoids-on-a-chip
    Jiafei Zhu, Anna Smothers Dressman, Kylee Gall, Sunghee Estelle Park · 2026 · Frontiers in Lab on a Chip Technologies
51. Mechanochemical regulation of organoid morphogenesis: Integrated signaling circuits in engineered microenvironments
    Xinxin Zhang, Yuanyuan Zhao, Lina Mao, Qiangsong Wang, Pengyu Huang · 2026 · Materials Today Bio
52. Harnessing human tumor organoids for cancer modeling and precision therapy
    Tonghai Zhou, Qianyi Wang, Zhang Mei-li, Yue Huang · 2026 · Protein & Cell
53. Synergistic immunotherapeutic effects of irreversible electroporation and CAR-NK cell therapy against hepatocellular carcinoma
    Joo Dong Park, Ha Eun Shin, Hye Jung Jang, Si Mon Ko, Yeon Su An, Jun Seob Lee, Sehoon Moon, Hyungseok Seo, Yewon Kim, Yohan Kim et al. · 2026 · Signal Transduction and Targeted Therapy
54. A Self-Assembling Peptide as a Model for Detection of Colorectal Cancer
    Yuan Wan, Ruyue Luo, Jialei Chen, Xinyi Luo, Guicen Liu, Di Su, Na Lu, Qichen Liu, Zhongli Luo · 2022 · Gels
55. Progress in patient-derived liver cancer cell models: a step forward for precision medicine
    Zhengtao Zhang, Lijian Hui · 2023 · Acta Biochimica et Biophysica Sinica
56. Cellulose nanofibril matrix drives the dynamic formation of spheroids
    Yi Lü, Li Guo, Yeqiu Li, Yuan Yao · 2023 · Journal of Zhejiang University SCIENCE B
57. Interferon-β Overexpression in Adipose Tissue-Derived Stem Cells Induces HepG2 and Macrophage Cell Death in Liver Tumor Organoids via Induction of TNF-Related Apoptosis-Inducing Ligand Expression
    Yongdae Yoon, Chang Wan Kim, Moon Young Kim, Soon Koo Baik, Pil Young Jung, Young Woo Eom · 2024 · International Journal of Molecular Sciences
58. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines
    Fangling Cheng, Pengcheng Li, Sanpeng Xu, Chao Zhang, Huifang Liang, Zeyang Ding · 2024 · Aging
59. Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol
    Tan Boon Toh, Dexter Kai Hao Thng, Nagarjun Bolem, Balamurugan A. Vellayappan, Bryce Wei Quan Tan, Yating Shen, Sou Yen Soon, Yvonne Li En Ang, Nivedh Dinesh, Kejia Teo et al. · 2024 · PLoS ONE
60. Patient-derived organoid models to decode liver pathophysiology
    Benjamin J. Dwyer, Janina E. E. Tirnitz‐Parker · 2024 · Trends in Endocrinology and Metabolism
61. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine
    Jelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, Marija Grozdanić, Ana Podolski-Renić, Milica Pešić · 2024 · Life
62. DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sites
    Teodor G. Calina, Eilís Pérez, Elena Grafenhorst, Jamal K. Benhamida, Simon Schallenberg, Adrian Popescu, Ines Koch, Tobias Janik, Baoqing Chen, Jana Ihlow et al. · 2024 · Clinical Epigenetics
63. Miniaturization and characterization of patient derived hepatocellular carcinoma tumor organoid cultures for cancer drug discovery applications
    David A. Close, Paul A. Johnston · 2024 · SLAS discovery : advancing life sciences R & D
64. Using organoid models to predict chemotherapy efficacy: the future of precision oncology?
    Steven Donald Forsythe, Tracey Pu, Aleksander Skardal · 2019 · Expert Review of Precision Medicine and Drug Development
65. Feasibility of primary human cell cultures as a model for adamantinomatous craniopharyngioma research: Evidence from RNA‑Seq analysis
    Peidong Zhang, Chao‐Hu Wang, Jun Fan, Junxiang Peng, Jun Pan, Songtao Qi, Yi Liu · 2020 · Oncology Letters
66. Phenotypic screening system using three-dimensional (3D) culture models for natural product screening
    Hikaru Suenaga, Noritaka Kagaya, Manabu Kawada, Daisuke Tatsuda, Toshiro Sato, Kazuo Shin‐ya · 2021 · The Journal of Antibiotics
67. Human Organoid and Supporting Technologies for Cancer and Toxicological Research
    Keisuke Sekine · 2021 · Frontiers in Genetics
68. Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
    Lillian van Biljon, Bisiayo Fashemi, Jeimmy Rodriguez, Olivia Graham, Amanda J. Compadre, Katherine Cynthia Fuh, Dineo Khabele, Mary Mullen · 2023 · Journal of Visualized Experiments
69. Protocol for inducing branching morphogenesis in human cholangiocyte and cholangiocarcinoma organoids
    Kimberley Ober, Floris J.M. Roos, Gilles S. van Tienderen, Kübra Köten, Annelot Klaassen, Wunan Mi, Luc J. W. van der Laan, Monique M. A. Verstegen · 2023 · STAR Protocols
70. An Exploration of Organoid Technology: Present Advancements, Applications, and Obstacles
    Isha Mishra, Komal Gupta, Raghav Mishra, Kajal Chaudhary, Vikram Sharma · 2023 · Current Pharmaceutical Biotechnology
71. Patient-derived organoid elucidates the identical clonal origin of bilateral breast cancer with diverse molecular subtypes
    Zhongbin Han, Liangxue Yao, Yanhua Fang, Sijing Chen, Ruiqing Lian, Yongqiang Yao, Hongsheng Chen, Xuening Ji, Weiting Yu, Zhe Wang et al. · 2024 · Frontiers in Oncology
72. Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids
    Zhian Xiu, Qian Yang, Fusheng Xie, Feng Han, Weiwei He, Weifang Liao · 2024 · Journal of Tissue Engineering
73. An advanced culture methodology suitable for the self-assemble and tissue-fragment derived intrahepatic cholangiocarcinoma organoids
    Chen Wang, Ao Huang, Yanghua Shi, Jiping Liu, Lanyang Li, Jian Zhang, Mingjie Rong, Xin Zhang, Chunhui Cai, Xinxin Han · 2024 · Cell organoid (Print)
74. Conversion therapy in advanced perihilar cholangiocarcinoma based on patient-derived organoids: A case report
    Yonggang He, Lingyu Zhang, Jing Li, Zheng Wang, Chong-Yu Zhao, Lu Zheng, Xiaobing Huang · 2024 · World Journal of Gastrointestinal Oncology
75. Generation of patient-derived glioblastoma organoids: a comparative study of enzymatic digestion and mechanical fragmentation methods
    Jian Zhang, Jiping Liu, Yanghua Shi, Lanyang Li, Chen Wang, Mingjie Rong, Bangbao Tao, Hong Tan, Wei Deng, Chunhui Cai et al. · 2024 · Cell organoid (Print)
76. Construction methods and latest applications of kidney cancer organoids
    Zhiqiang Li, Yanqiu You, Bo Feng, Jibing Chen, Hongjun Gao, Fujun Li · 2024 · Oncology Reviews
77. Hua Zheng San Ji Fang suppresses liver cancer progression by inhibiting TYRO3 expression via the ERK signaling pathway
    Zhuang Xiong, Xiaodan Sui, Yu Bai, Yangyang Liu, Yan Leng, Song Wang, Boyang Su, Zhiyuan Liu, Tiejun Liu · 2025 · Phytomedicine
78. The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids
    Corinna Boden, Laura Kristin Esser, Leona Dold, Bettina Langhans, Taotao Zhou, Dominik J. Kaczmarek, Maria Angeles Gonzalez-Carmona, Tobias J. Weismüller, Glen Kristiansen, Jörg C. Kalff et al. · 2025 · Biomedicines
79. Patient-Derived Organoids: Promises, Hurdles and Potential Clinical Applications
    Somaieh Hedayat, Nicola Valeri · 2020 · Clinical Oncology
80. Isolated cancer stem cells from human liver cancer: morphological and functional characteristics in primary culture
    M. Hu, M. Li, Huichao Huang, Caijie Lu · 2021 · Clinical & Translational Oncology
81. Review: Challenges of In Vitro CAF Modelling in Liver Cancers
    Alba Herrero, Elisabeth Knetemann, Inge Mannaerts · 2021 · Cancers
82. Advances and applications of biofiber polymer composites in regenerative medicine
    Dillip Kumar Bishi, Santosh Mathapati, Priyadarshini Padhi, K.S. Venkataprasanna, Hariharan Ezhilarasu, Raghavendra Ramalingam, Mohd Hasbi Ab. Rahim, Jayarama Reddy Venugopal · 2022 · Elsevier eBooks
83. Physiomimetic In Vitro Human Models for Viral Infection in the Liver
    Dennis McDuffie, David Barr, Madeline Helm, Thomas F. Baumert, Ashutosh Agarwal, Emmanuel Thomas · 2022 · Seminars in Liver Disease
84. Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma
    Meimei Li, Fan-En Kong, Guangmeng Li, Yi-Ti He, Xiao-Feng Zhang, Chengyang Zhang, Jie-Kai Liang, Xin‐Yuan Guan, Ning‐Fang Ma, Maobin Xie et al. · 2022 · STAR Protocols
85. Preclinical models in oncological pharmacology: limits and advantages
    Ester Pagano, Alberta Bergamo, Sara Carpi, Sandra Donnini, Monica Notarbartolo Di Villarosa, Loredana Serpe, Lucia Lisi · 2021
86. Generative Ai for Cardiovascular Cell Type‐Specific Fluorescence Colorization of Live‐Cell hPSC‐Derived Cardiac Organoids
    Arun Kumar Reddy Kandula, Tanakit Phamornratanakun, Angello Huerta Gomez, Marcel El‐Mokahal, Zhen Ma, Yunhe Feng, Huaxiao Yang · 2025 · Advanced Intelligent Discovery
87. Advancing oral squamous cell carcinoma research: the evolving role of patient-derived cell lines, xenografts, and organoid models
    Vinal Upadhyay, Sourav Das, Amisha Nehru, Uppalpati Sai Swetha, Priyanka Patel Vatsa, Ambika Chamoli, Amit Mandoli · 2025 · 3 Biotech
88. Evolution and hotspots in breast cancer organoid research: insights from a bibliometric and visual knowledge mapping study (2005-2024)
    Tao Wu, Bo Li, Lei Hao, FuXing Zhao, Zhen Liu · 2025 · Frontiers in Oncology
89. Mycobacterial Tyrosine Phosphatase PtpB Affects Host Cytokine Expression by Dephosphorylating ERK1/2 and STAT3
    Tianxian Liu, Yameng Fan, Yijia Chen, Shuyu Xie, Jun‐Yu Xu, Minjia Tan, Bang‐Ce Ye · 2025 · Molecular & Cellular Proteomics
90. Patient-derived organoids in non-small cell lung cancer: advances in drug sensitivity testing
    Wanyu Tang, Xudong Tian · 2026 · Frontiers in Pharmacology
91. Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects
    Ruiyang Li, Yuezhou Wu, Zhu'anzhen Zheng, Fengjin Zhou, Ke Xu, Jiacan Su · 2026 · MedComm
92. Human Liver Organoids as an Experimental Tool to Investigate Lipocalin-2 in Hepatic Inflammation
    Katja Hardt, Robert F. Pohlberger, Diandra T. Keller, Eva Miriam Buhl, Florian W. R. Vondran, Anjali A. Roeth, Ralf Weiskirchen, Sarah K. Schröder · 2026 · Cells
93. Organoid Models: Revolutionizing Disease Modeling and Personalized Therapeutics
    Zhifeng Xue, Runze Yang, Yaling Liu, Han Luo · 2026 · Organoids
94. Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma
    J Park, Meiyu Qiu, Eun Jeong Cho, Sanghee Seo, Ji-Hoon Moon, M U Kim, Hyemin Mun, Hyounji Yun, Hoewon Park, 임아림 et al. · 2026 · Cell Reports Medicine
95. Review on Advanced Cancer Modeling for a Cancer Study
    Yong‐Hee Cho · 2022 · Current Issues in Molecular Biology
96. Innovative explorations: unveiling the potential of organoids for investigating environmental pollutant exposure
    Yuanhang Zhang, Kai Liu, Huan He, Hui Xiao, Zhihong Fang, Xianxian Chen, Huiming Li · 2024 · Environmental Science and Pollution Research
97. Global Literature Analysis of Tumor Organoid and Tumor-on-Chip Research
    Jun‐ya Shoji, Richard P. Davis, Christine L. Mummery, Stefan Johannes Karl Krauss · 2025 · Cancers
98. Human corneal organoid has a limbal function that supplies epithelium to the cornea with limbal deficiency
    Kazunari Higa, Mifuyu Ishiwata, Reona Kimoto, Masatoshi Hirayama, Takefumi Yamaguchi, Shigeto Shimmura · 2025 · Regenerative Therapy
99. Microfluidic manipulation of the multicellular spheroids and organoids for modeling human diseases
    Liang Zhao, Siyi Xiong, Dan Wang, Xiayan Wang · 2025 · Microchemical Journal
100. Apoptosis regulators of the Bcl‐2 family play a key role in chemoresistance of cholangiocarcinoma organoids
     Wunan Mi, Gilles S. van Tienderen, Shaojun Shi, Amy Broeders, Kathryn Monfils, Henk P. Roest, Luc J. W. van der Laan, Monique M. A. Verstegen · 2025 · International Journal of Cancer